Success Metrics

Clinical Success Rate
75.0%

Based on 6 completed trials

Completion Rate
75%(6/8)
Active Trials
1(8%)
Results Posted
33%(2 trials)
Terminated
2(17%)

Phase Distribution

Ph not_applicable
6
50%
Ph phase_2
1
8%
Ph phase_3
2
17%
Ph phase_4
2
17%

Phase Distribution

0

Early Stage

1

Mid Stage

4

Late Stage

Phase Distribution11 total trials
Phase 2Efficacy & side effects
1(9.1%)
Phase 3Large-scale testing
2(18.2%)
Phase 4Post-market surveillance
2(18.2%)
N/ANon-phased studies
6(54.5%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

75.0%

6 of 8 finished

Non-Completion Rate

25.0%

2 ended early

Currently Active

1

trials recruiting

Total Trials

12

all time

Status Distribution
Active(2)
Completed(6)
Terminated(2)
Other(2)

Detailed Status

Completed6
Terminated2
unknown2
Not yet recruiting1
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
12
Active
1
Success Rate
75.0%
Most Advanced
Phase 4

Trials by Phase

Phase 21 (9.1%)
Phase 32 (18.2%)
Phase 42 (18.2%)
N/A6 (54.5%)

Trials by Status

not_yet_recruiting18%
completed650%
terminated217%
unknown217%
active_not_recruiting18%

Recent Activity

Clinical Trials (12)

Drug Details

Intervention Type
DRUG
Total Trials
12